Ranbaxy Laboratories Limited Stock

Stocks

End-of-day quote NSE India S.E.
- ^INR	-

07/03/16	UCB : Pharma crusader takes India's drug regulators to court	RE
29/06/15	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

07/03/16	UCB : Pharma crusader takes India's drug regulators to court	RE
29/06/15	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
20/04/15	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
30/01/15	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
05/12/14	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
20/11/14	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
18/11/14	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
28/10/14	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
31/07/14	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
25/07/14	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
17/07/14	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
24/06/14	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
19/06/14	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

04/03/15	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
28/01/15	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
06/12/14	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
01/12/14	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
29/07/14	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

17/07/14	Novartis : confirme l'objectif de croissance de ses ventes
17/07/14	Novartis : confirme l'objectif de croissance du C.A. annuel
19/06/14	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
22/04/14	S& 500 : Vague de fusions dans le domaine de la pharmacie
07/04/14	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+4.27%	+0.17%	+46.21%	+139.01%	1,206B
JOHNSON & JOHNSON	+2.13%	+4.27%	+49.73%	+91.36%	665B
ABBVIE INC.	+0.68%	+1.54%	+34.10%	+112.47%	515B
ROCHE HOLDING AG	+2.77%	-0.57%	+49.44%	+68.42%	381B
MERCK & CO., INC.	+1.36%	+0.16%	+71.29%	+45.14%	362B
NOVARTIS AG	+0.29%	-0.24%	+30.84%	+57.23%	307B
ASTRAZENECA PLC	+0.98%	+0.76%	+9.04%	+38.31%	289B
AMGEN INC.	+1.04%	-0.04%	+43.76%	+76.20%	249B
GILEAD SCIENCES, INC.	+1.46%	-0.52%	+43.41%	+125.98%	207B
Average	+1.44%	-1.54%	+41.98%	+83.79%	464.42B
Weighted average by Cap.	+1.75%	-1.96%	+43.76%	+96.27%

Employees

Sector